Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of TAK-925 Study in Sleep-Deprived Healthy Adults [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating safety, tolerability, PK and PD of TAK-925 in sleep-deprived healthy adults has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Volunteers

Drugs mentioned

• TAK-925

Snippet

Sponsor: Takeda | Conditions: Healthy Volunteers | Phase 1 | Status: COMPLETED | Results posted: 2019-11-26